Julie Anne Blake

US Patent:

20050107588, May 19, 2005

Filed:

Nov 13, 2002

Appl. No.:

10/495148

Inventors:

Brendan Duggan - Sunnyvale CA, US
Junming Yang - San Jose CA, US
Kimberly Gietzen - San Jose CA, US
Soo Lee - Mountain View CA, US
Y. Tang - San Jose CA, US
Yalda Azimzai - Oakland CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - San Marcos CA, US
Ines Barroso - Cambridge, GB
Shanya Becha - San Francisco CA, US
Henry Yue - Sunnyvale CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Sally Lee - San Jose CA, US
Brooke Emerling - Chicago IL, US
Amy Kable - Silver Spring MD, US
Reena Khare - Saratoga CA, US
Mariah Baughn - Los Angeles CA, US
Ameena Gandhi - San Francisco CA, US
Uyen Tran - San Jose CA, US
Thomas Richardson - Redwood City CA, US
Joseph Marquis - San Jose CA, US
Preeti Lal - Santa Clara CA, US
Ian Forsythe - Edmonton, CA
Ernestine Lee - Kensington CA, US
Anita Swarnakar - San Francisco CA, US
Deborah Kallick - Galveston TX, US
Jennifer Griffin - Fremont CA, US
Vicki Elliott - San Jose CA, US
Ann Gorvad - Bellingham WA, US
April Hafalia - Daly City CA, US
Craig Ison - San Jose CA, US
Pei Jin - Palo Alto CA, US
Xin Jiang - Saratoga CA, US
Alan Jackson - Los Gatos CA, US
Umesh Bhatia - San Jose CA, US
John Burrill - Redwood City CA, US
Julie Blake - San Francisco CA, US
Anne Ho - Sunnyvale CA, US
Wenjin Zheng - San Diego CA, US
Jing Gao - Santa Clara CA, US

International Classification:

C07K014/705
C07H021/04

US Classification:

530350000, 435069100, 435320100, 435325000, 536023500

Abstract:

Various embodiments of the invention provide human receptors and membrane-associated proteins (REMAP) and polynucleotides which identify and encode REMAP. Embodiments of the invention also provide expression vectors, host cells, anti-bodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of REMAP.

US Patent:

20050123912, Jun 9, 2005

Filed:

Aug 14, 2002

Appl. No.:

10/486977

Inventors:

Ines Barroso - Cambridge, GB
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Julie Blake - San Francisco CA, US
Mark Borowsky - Needham MA, US
Neil Burford - Durham CT, US
Brendan Duggan - Sunnyvale CA, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ian Forsythe - Edmonton, CA
Kimberly Gietzen - San Jose CA, US
Ann Gorvad - Bellingham WA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Cynthia Honchell - San Francisco CA, US
Craig Ison - San Jose CA, US
Farrah Khan - Canton MI, US
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Kensington CA, US
Sally Lee - San Jose CA, US
Soo Lee - Mountain View CA, US
Joana Li - Millbrae CA, US
Dyung Lu - San Jose CA, US
Yan Lu - Mountain View CA, US
Danniel Nguyen - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
William Sprague - Sacramento CA, US
Y Tang - San Jose CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Michael Thornton - Oakland CA, US
Uyen Tran - San Jose CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - San Marcos CA, US
Yuming Xu - Mountain View CA, US
Monique Yao - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Huibin Yue - Cupertino CA, US
Yeganeh Zebarjadian - San Francisco CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/22

US Classification:

435006000, 435069100, 435199000, 435320100, 435325000, 536023200

Abstract:

Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.

US Patent:

20050191627, Sep 1, 2005

Filed:

Sep 26, 2002

Appl. No.:

10/491183

Inventors:

Junming Yang - San Jose CA, US
Aina Dyung Lu - San Jose CA, US
Henry Yue - Sunnyvale CA, US
Vicki Elliott - San Jose CA, US
Bridget Warren - Encinitas CA, US
Brendan Duggan - Sunnyvale CA, US
Ian Forsythe - Redwood City CA, US
Ernestine Lee - Castro Valley CA, US
April Hafalia - Santa Clara CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Narinder Chawla - Union City CA, US
Mariah Baughn - San Leandro CA, US
Shanya Becha - Castro Valley CA, US
Ann Gorvad - Livermore CA, US
Uyen Tran - San Jose CA, US
Joana Li - San Francisco CA, US
Monique Yao - Carmel IN, US
Craig Ison - San Jose CA, US
Jennifer Griffin - Fremont CA, US
Soo Lee - Daly City CA, US
Hsin-Ru Chang - Belmont CA, US
Brooke Emerling - Palo Alto CA, US
Tom Tang - San Jose CA, US
Preeti Lal - Santa Clara CA, US
Amy Kable - San Francisco CA, US
Joseph Marquis - San Jose CA, US
Xin Jiang - Saratoga CA, US
Alan Jackson - Los Gatos CA, US
Yeganeh Zebarjadian - San Francisco CA, US
Anita Swarnakar - San Francisco CA, US
Amy Wilson - Belmont CA, US
Pei Jin - Palo Alto CA, US
Thomas Richardson - Redwood City CA, US
Umesh Bhatia - San Jose CA, US
John Burrill - Redwood City CA, US
Sally Lee - San Francisco CA, US
Julie Blake - San Francisco CA, US
Anne Ho - Sunnyvale CA, US
Wenjin Zheng - Mountain View CA, US
Jin Gao - Sunnyvale CA, US

Assignee:

Incyte Corporation - Palo Alto CA

International Classification:

C12Q001/68
G01N033/53
C07H021/04
C12N009/00

US Classification:

435006000, 435007100, 435069100, 435183000, 435320100, 435325000, 536023200

Abstract:

Various embodiments of the invention provide human enzymes (ENZM) and polynucleotides which identify and encode ENZM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of ENZM.

US Patent:

20070276126, Nov 29, 2007

Filed:

Aug 12, 2003

Appl. No.:

10/524355

Inventors:

Vicki Elliott - San Jose CA, US
Reena Khare - Saratoga CA, US
Brooke Emerling - Chicago IL, US
Amy Kable - Silver Spring MD, US
Uyen Tran - San Jose CA, US
Pei Jin - Palo Alto CA, US
Shanya Becha - San Francisco CA, US
Joseph Marquis - San Jose CA, US
Anita Swarnakar - San Francisco CA, US
Narinder Chawla - Union City CA, US
Jayalaxmi Ramkumar - Fremont CA, US
April Hafalia - Daly City CA, US
Soo Lee - Mountain View CA, US
Xin Jiang - Saratoga CA, US
Alan Jackson - Los Gatos CA, US
Thomas Richardson - Redwood City CA, US
Julie Blake - San Francisco CA, US
Jonathan Wang - Mountain View CA, US
David Chien - Davis CA, US
Yonghong Yang - San Jose CA, US

International Classification:

C07K 14/705
C12Q 1/68
G06F 19/00
C07H 21/04
C12P 21/06
G01N 33/50

US Classification:

530350000, 702019000, 435006000, 435069100, 435320100, 435325000, 530388100, 536023500

Abstract:

Various embodiments of the invention provide human cell adhesion and extracellular matrix proteins (CADECM) and polynucleotides which identify and encode CADECM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CADECM.

US Patent:

20040254350, Dec 16, 2004

Filed:

Mar 19, 2004

Appl. No.:

10/490318

Inventors:

Anne Ho - Sunnyvale CA, US
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Neil Burford - Durham CT, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ian Forsythe - Edmonton, CA
Ann Gorvad - Bellingham WA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Cynthia Honchell - San Francisco CA, US
John Burrill - Redwood City CA, US
Julie Blake - San Francisco CA, US
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Kensington CA, US
Joseph Marquis - San Jose CA, US
Sally Lee - San Jose CA, US
William Sprague - Sacramento CA, US
Anita Swarnakar - San Francisco CA, US
Y Tang - San Jose CA, US
Bao Tran - Cupertino CA, US
Uyen Tran - San Jose CA, US
Umesh Bhatia - San Jose CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - San Marcos CA, US
Wenjin Zheng - San Diego CA, US
Yuming Xu - Mountain View CA, US
Henry Yue - Sunnyvale CA, US

International Classification:

C07K014/705
C07H021/04

US Classification:

530/350000, 435/069100, 435/320100, 435/325000, 536/023500

Abstract:

various embodiments of the invention provide human immune response associated proteins (TRAP) and polynucleotides which identify and encode IRAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of IRAP.